TIDMAGY

RNS Number : 4607X

Allergy Therapeutics PLC

19 November 2014

19 November 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the 'Company")

Result of Annual General Meeting

Allergy Therapeutics plc announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.

For further information

 
 Allergy Therapeutics                   +44 (0) 1903 845 820 
 Manuel Llobet, Chief Executive 
  Officer 
 Ian Postlethwaite, Finance Director 
 
 Peel Hunt LLP                          +44 (0) 20 7418 8900 
 James Steel 
 Clare Terlouw 
 
 FTI Consulting                         +44 (0) 20 3727 1000 
 Simon Conway 
 Victoria Foster Mitchell

Note to editors

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.Ithas a growing business achieving revenue in thelast financial year of GBP42 million mainly in Europe through its own sales and

marketing infrastructure and further afield through distributors.The Company is expanding its infrastructure into the Emerging markets.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFFSFDUFLSEFF

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allergy Therapeutics Charts.